Therapeutic Drug Class Cases in Federal Circuit

Browse 1 therapeutic drug class cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Defendant Win

Therapeutic Drug Class Opinions from Federal Circuit (1)

Actavis Laboratories Fl, Inc. v. United States

Federal Circuit Clarifies Medicare Part D 'Substantially All' Drug Reimbursement Rule

Federal Circuit · 2025-03-21 · Defendant Win · Impact: 40/100

Actavis Laboratories Fl, Inc. v. United States, decided by Federal Circuit on March 21, 2025, resulted in a defendant win outcome. The case concerns the interpretation of the "substantially all" limit...

Frequently Asked Questions

Q: How many therapeutic drug class cases has Federal Circuit decided?

CaseLawBrief currently tracks 1 therapeutic drug class cases from Federal Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in therapeutic drug class cases at Federal Circuit?

Outcome breakdown: Defendant Win: 1.

Q: Where can I find plain English summaries of therapeutic drug class rulings from Federal Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All Federal Circuit Cases All Therapeutic Drug Class Cases All Courts All Topics Search